Psychiatric morbidity and quality of life in children and adolescents with cystic fibrosis

dc.contributor.authorŞenses-Dinç, Gülser.
dc.contributor.authorÖzçelik, Uğur
dc.contributor.authorÇak, Tuna.
dc.contributor.authorDoğru-Ersöz, Deniz.
dc.contributor.authorÇöp, Esra.
dc.contributor.authorYalçın, Ebru.
dc.contributor.authorÇengel-Kültür, Ebru.
dc.contributor.authorPekcan, Sevgi.
dc.contributor.authorKiper, Nural.
dc.contributor.authorÜnal, Fatih.
dc.date.accessioned2020-03-26T20:11:50Z
dc.date.available2020-03-26T20:11:50Z
dc.date.issued2018
dc.departmentSelçuk Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü.en_US
dc.description.abstractThe aim of this study was to investigate psychiatric disorders, depression and anxiety levels, and quality of life in children and adolescents with cystic fibrosis (CF), and to compare them with those of children with non-cystic fibrosis (non-CF) bronchiectasis and healthy controls. A total of 103 children and adolescents aged 7-16 years (35 CF, 28 non-CF bronchiectasis, 40 healthy) were evaluated using The Schedule for Affective Disorders and Schizophrenia for School Aged Children (K-SADS), The Child Depression Inventory (CDI), The State-Trait Anxiety Inventories for Children (STAI-C) and the Pediatric Quality of Life Inventory (PedsQL)-C. The three groups were not statistically different with respect to age, sex, and familial sociodemographic variables. 80% of the children and adolescents in the CF group were diagnosed with a psychiatric disorder, which was significantly more compared to those of the two other groups. The CF group had significantly greater rates of depressive and oppositional defiant disorder and the non-bronchiectasis group had a significantly greater rate of anxiety disorder than the control group. The depression and anxiety symptom levels were significantly greater and the quality of life levels significantly lower in both the CF and non-CF bronchiectasis groups than the healthy controls. In the CF group, the presence of any associated psychiatric disorder led to significantly lower total and psychosocial quality of life scores. In conclusion, CF is associated with poorer QOL in childhood. In order to improve quality of life in CF, the psychiatric conditions of children and adolescents should also be evaluated and their follow-up and treatment should involve a multidisciplinary team approach. © 2018, Turkish Journal of Pediatrics. All rights reserved.en_US
dc.identifier.citationDinç, G. Ş., Özçelik, U., Çak, T., Ersöz, D. D., Çöp, E., Yalçın, E., Kültür, E. Ç., Pekcan, S., Kiper, N., Ünal, F. (2018). Psychiatric Morbidity and Quality of Life in Children and Adolescents with Cystic Fibrosis. Turkish Journal of Pediatrics, 60, 32-40.
dc.identifier.doi10.24953/turkjped.2018.01.005en_US
dc.identifier.endpage40en_US
dc.identifier.issn0041-4301en_US
dc.identifier.issue1en_US
dc.identifier.pmid30102477en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage32en_US
dc.identifier.urihttps://dx.doi.org/10.24953/turkjped.2018.01.005
dc.identifier.urihttps://hdl.handle.net/20.500.12395/37232
dc.identifier.volume60en_US
dc.identifier.wosWOS:000442043600005en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorPekcan, Sevgi.
dc.language.isoenen_US
dc.publisherTurkish Journal of Pediatricsen_US
dc.relation.ispartofTurkish Journal of Pediatricsen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjectChildrenen_US
dc.subjectCystic fibrosisen_US
dc.subjectPsychopathologyen_US
dc.subjectQuality of lifeen_US
dc.titlePsychiatric morbidity and quality of life in children and adolescents with cystic fibrosisen_US
dc.typeArticleen_US

Dosyalar